LD-2 disclosure · 3rd Quarter - Report
ALLERGAN INC (FORMERLY ACTAVIS INC )
Client
- Name
- ALLERGAN INC (FORMERLY ACTAVIS INC )
- Description
- Pharmaceutical manufacturer specializing in generic, brand and biosimilar products.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government affairs consulting
- Location
- Washington, DC, District of Columbia, United States of America
Lobbying activities
3 issuesCopyright/Patent/Trademark
Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Policy Analyst for Senate Republican Policy Comt.
Covered position (BRENDA REESE): Conference Coordinator for House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Worked on industry concerns related to S. 102, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; as well as S.1895, the Lower Health Care Costs Act.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Analyst for the Senate Republican Policy Committee
Covered position (BRENDA REESE): Conference Coordinator for the House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations